drugset / Trial / NCT07093073
Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open-label clinical study evaluating the efficacy and safety of U01 (ssCART-19) in patients with relapsed or refractory B-cell lymphoma.
Timeline
- Start
- 2025-01-23
- Primary completion
- 2027-01-31
- Completion
- 2029-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ssCART-19 | Cell therapy | — | — |